1593 second avenue LLC

1650 broadway suite 910
new york, new york 10019

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 20, 2014

NYS DOS ID#
4532122

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - 1593 SECOND AVENUE LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • Activist investor turns up heat on owner of Saks Fifth Avenue
    By Lisa Fickenscher - Monday Jul 31, 2017

    An activist investor is turning up the heat on Saks Fifth Avenue owner Hudson’s Bay Co. Hedge fund Land and Buildings fired off its second letter in six weeks to the board of Hudson’s Bay on Monday, threatening to remove board members if the department store company doesn’t sell some of its prized real estate....

    Source: New York Post: Business
  • Boomer Esiason signs on to promote electric grill
    By Claire Atkinson - Saturday Jul 29, 2017

    Just as pro football camps open up to condition the players for the upcoming season, advertisers are also drafting their pitch persons. Our spies say former NY Jets quarterback and current WFAN radio host Boomer Esiason has been on many Madison Avenue top-pick lists. The sports broadcaster just signed with Johnsonville to help promote the...

    Source: New York Post: Business
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
    By Ben Fidler - Thursday Aug 3, 2017

    Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]

    Source: Xconomy New York
1593 second avenue llc new york ny